BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32978103)

  • 1. Integrating clonal haematopoiesis into geriatric oncology: The ARCH between aging, cardiovascular disease and malignancy.
    Neuendorff NR; Frenzel LP; Leuschner F; Fremd C
    J Geriatr Oncol; 2021 Apr; 12(3):479-482. PubMed ID: 32978103
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clonal haematopoiesis is possibly a risk factor for cardiovascular disease].
    Hansen PR
    Ugeskr Laeger; 2020 Aug; 182(34):. PubMed ID: 32800058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of clonal haematopoiesis in cardiovascular diseases: epidemiology and experimental studies.
    Min KD; Kour A; Sano S; Walsh K
    J Intern Med; 2020 Nov; 288(5):507-517. PubMed ID: 32715520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal Hematopoiesis and Cardiovascular Diseases: The Connection.
    Mozzini C; Pagani M
    Curr Probl Cardiol; 2022 Oct; 47(10):100962. PubMed ID: 34391764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal haematopoiesis and cardiovascular diseases: A growing relationship.
    Fawaz S; Mansier O; Pucheu Y; Marti S; Leroy H; Gaufroy A; Broitman J; James C; Couffinhal T
    Arch Cardiovasc Dis; 2021 Apr; 114(4):316-324. PubMed ID: 33714721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Disease, Aging, and Clonal Hematopoiesis.
    Evans MA; Sano S; Walsh K
    Annu Rev Pathol; 2020 Jan; 15():419-438. PubMed ID: 31689371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study).
    David C; Duployez N; Eloy P; Belhadi D; Chezel J; Guern VL; Laouénan C; Fenwarth L; Rouzaud D; Mathian A; de Almeida Chaves S; Duhaut P; Fain O; Galicier L; Ghillani-Dalbin P; Kahn JE; Morel N; Perard L; Pha M; Sarrot-Reynauld F; Aumaitre O; Chasset F; Limal N; Desmurs-Clavel H; Ackermann F; Amoura Z; Papo T; Preudhomme C; Costedoat-Chalumeau N; Sacre K
    Rheumatology (Oxford); 2022 Nov; 61(11):4355-4363. PubMed ID: 35176141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure.
    Mooney L; Goodyear CS; Chandra T; Kirschner K; Copland M; Petrie MC; Lang NN
    Clin Sci (Lond); 2021 Apr; 135(7):991-1007. PubMed ID: 33861346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common and rare variant associations with clonal haematopoiesis phenotypes.
    Kessler MD; Damask A; O'Keeffe S; Banerjee N; Li D; Watanabe K; Marketta A; Van Meter M; Semrau S; Horowitz J; Tang J; Kosmicki JA; Rajagopal VM; Zou Y; Houvras Y; Ghosh A; Gillies C; Mbatchou J; White RR; Verweij N; Bovijn J; Parikshak NN; LeBlanc MG; Jones M; ; ; Glass DJ; Lotta LA; Cantor MN; Atwal GS; Locke AE; Ferreira MAR; Deering R; Paulding C; Shuldiner AR; Thurston G; Ferrando AA; Salerno W; Reid JG; Overton JD; Marchini J; Kang HM; Baras A; Abecasis GR; Jorgenson E
    Nature; 2022 Dec; 612(7939):301-309. PubMed ID: 36450978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential.
    Burns SS; Kapur R
    Stem Cell Reports; 2020 Aug; 15(2):292-306. PubMed ID: 32735822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease.
    Kumar P; Kopecky SL; Yang EH; Oren O
    Curr Oncol Rep; 2020 Jul; 22(9):87. PubMed ID: 32643015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease.
    Ehlert CA; Hilgendorf I
    Hamostaseologie; 2021 Dec; 41(6):443-446. PubMed ID: 34942657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal haematopoiesis of emerging significance.
    Hammond D; Loghavi S
    Pathology; 2021 Apr; 53(3):300-311. PubMed ID: 33685721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal haematopoiesis, ageing and kidney disease.
    Vlasschaert C; Lanktree MB; Rauh MJ; Kelly TN; Natarajan P
    Nat Rev Nephrol; 2024 Mar; 20(3):161-174. PubMed ID: 37884787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine models of clonal haematopoiesis to assess mechanisms of cardiovascular disease.
    Wang Y; Sano S; Ogawa H; Horitani K; Evans MA; Yura Y; Miura-Yura E; Doviak H; Walsh K
    Cardiovasc Res; 2022 May; 118(6):1413-1432. PubMed ID: 34164655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.
    Libby P; Sidlow R; Lin AE; Gupta D; Jones LW; Moslehi J; Zeiher A; Jaiswal S; Schulz C; Blankstein R; Bolton KL; Steensma D; Levine RL; Ebert BL
    J Am Coll Cardiol; 2019 Jul; 74(4):567-577. PubMed ID: 31345432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
    Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
    J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline risk of clonal haematopoiesis.
    Silver AJ; Bick AG; Savona MR
    Nat Rev Genet; 2021 Sep; 22(9):603-617. PubMed ID: 33986496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between Clonal Hematopoiesis of Indeterminate Potential and Metabolism.
    Lee MKS; Dragoljevic D; Bertuzzo Veiga C; Wang N; Yvan-Charvet L; Murphy AJ
    Trends Endocrinol Metab; 2020 Jul; 31(7):525-535. PubMed ID: 32521236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal haematopoiesis and atherosclerotic cardiovascular disease.
    Ahmad H; Jaiswal S
    Nat Rev Cardiol; 2023 Jul; 20(7):437-438. PubMed ID: 37169832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.